Login / Signup

Reply to Dr Finsterer; CSF biomarkers of neuronal/glial damage or immune activation are unsuitable for assessing post-COVID cognitive impairment.

Nelly KanbergMichael SchöllArvid EdénMagnus Gisslén
Published in: The Journal of infectious diseases (2023)
Keyphrases
  • cognitive impairment
  • coronavirus disease
  • sars cov
  • oxidative stress
  • editorial comment
  • neuropathic pain
  • cerebral ischemia
  • respiratory syndrome coronavirus
  • cerebrospinal fluid
  • blood brain barrier